RT Journal Article SR Electronic T1 Deprescribing in palliative care JF Clinical Medicine JO Clin Med FD Royal College of Physicians SP 311 OP 314 DO 10.7861/clinmedicine.19-4-311 VO 19 IS 4 A1 Jo Thompson YR 2019 UL http://www.rcpjournals.org/content/19/4/311.abstract AB The use of multiple medications is common in palliative care, putting patients at risk of adverse events and a high tablet burden. Deprescribing is the process of reviewing and stopping potentially inappropriate medications in order to improve quality of life. Barriers to deprescribing exist meaning many patients will take multiple medications despite being in the final months of life. The OncPal deprescribing guideline is a useful tool to support the process for patients with a limited life expectancy. There is evidence for the safety of stopping certain medications, particularly those aimed at primary prevention. A systematic process of reviewing individual medications and their appropriateness is recommended.